These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33419227)

  • 1. N-Glycosylation as a Tool to Study Antithrombin Secretion, Conformation, and Function.
    Águila S; Noto R; Luengo-Gil G; Espín S; Bohdan N; de la Morena-Barrio ME; Peñas J; Rodenas MC; Vicente V; Corral J; Manno M; Martínez-Martínez I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33419227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin.
    Aguila S; Martínez-Martínez I; Dichiara G; Gutiérrez-Gallego R; Navarro-Fernández J; Vicente V; Corral J
    PLoS One; 2014; 9(12):e114454. PubMed ID: 25485983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The infective polymerization of conformationally unstable antithrombin mutants may play a role in the clinical severity of antithrombin deficiency.
    Martínez-Martínez I; Navarro-Fernández J; Aguila S; Miñano A; Bohdan N; De La Morena-Barrio ME; Ordóñez A; Martínez C; Vicente V; Corral J
    Mol Med; 2012 Jul; 18(1):762-70. PubMed ID: 22481271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation.
    Martínez-Martínez I; Ordóñez A; Navarro-Fernández J; Pérez-Lara A; Gutiérrez-Gallego R; Giraldo R; Martínez C; Llop E; Vicente V; Corral J
    Haematologica; 2010 Aug; 95(8):1358-65. PubMed ID: 20435622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of the severity of heparin-binding antithrombin mutations by posttranslational mosaicism.
    Martínez-Martínez I; Navarro-Fernández J; Østergaard A; Gutiérrez-Gallego R; Padilla J; Bohdan N; Miñano A; Pascual C; Martínez C; de la Morena-Barrio ME; Aguila S; Pedersen S; Kristensen SR; Vicente V; Corral J
    Blood; 2012 Jul; 120(4):900-4. PubMed ID: 22498748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect.
    de la Morena-Barrio ME; Martínez-Martínez I; de Cos C; Wypasek E; Roldán V; Undas A; van Scherpenzeel M; Lefeber DJ; Toderici M; Sevivas T; España F; Jaeken J; Corral J; Vicente V
    J Thromb Haemost; 2016 Aug; 14(8):1549-60. PubMed ID: 27214821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays.
    de la Morena-Barrio ME; Suchon P; Jacobsen EM; Iversen N; Miñano A; de la Morena-Barrio B; Bravo-Pérez C; Padilla J; Cifuentes R; Asenjo S; Deleuze JF; Trégouët DA; Lozano ML; Vicente V; Sandset PM; Morange PE; Corral J
    Blood; 2022 Jul; 140(2):140-151. PubMed ID: 35486842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of latent antithrombin in plasma from patients with antithrombin deficiency.
    de la Morena-Barrio M; Sandoval E; Llamas P; Wypasek E; Toderici M; Navarro-Fernández J; Rodríguez-Alen A; Revilla N; López-Gálvez R; Miñano A; Padilla J; de la Morena-Barrio B; Cuesta J; Corral J; Vicente V
    Thromb Haemost; 2017 May; 117(5):880-888. PubMed ID: 28229161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities.
    Águila S; Izaguirre G; Martínez-Martínez I; Vicente V; Olson ST; Corral J
    J Biol Chem; 2017 Oct; 292(40):16513-16520. PubMed ID: 28743742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetics of antithrombin.
    Corral J; de la Morena-Barrio ME; Vicente V
    Thromb Res; 2018 Sep; 169():23-29. PubMed ID: 30005274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular folding pathway of a metastable serpin.
    Chandrasekhar K; Ke H; Wang N; Goodwin T; Gierasch LM; Gershenson A; Hebert DN
    Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6484-9. PubMed ID: 27222580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of an additional glycosylation site as a mechanism for type I antithrombin deficiency.
    Fitches AC; Lewandowski K; Olds RJ
    Thromb Haemost; 2001 Oct; 86(4):1023-7. PubMed ID: 11686319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene analysis of inherited antithrombin deficiency and functional analysis of abnormal antithrombin protein (N87D).
    Kamijima S; Sekiya A; Takata M; Nakano H; Murakami M; Nakazato T; Asakura H; Morishita E
    Int J Hematol; 2018 Apr; 107(4):490-494. PubMed ID: 29071478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and characterization of recombinant human antithrombin III in Pichia pastoris.
    Mochizuki S; Hamato N; Hirose M; Miyano K; Ohtani W; Kameyama S; Kuwae S; Tokuyama T; Ohi H
    Protein Expr Purif; 2001 Oct; 23(1):55-65. PubMed ID: 11570846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombin Dublin (p.Val30Glu): a relatively common variant with moderate thrombosis risk of causing transient antithrombin deficiency.
    Navarro-Fernández J; de la Morena-Barrio ME; Padilla J; Miñano A; Bohdan N; Águila S; Martínez-Martínez I; Sevivas TS; de Cos C; Fernández-Mosteirín N; Llamas P; Asenjo S; Medina P; Souto JC; Overvad K; Kristensen SR; Corral J; Vicente V
    Thromb Haemost; 2016 Jul; 116(1):146-54. PubMed ID: 27098529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST; Frances-Chmura AM; Swanson R; Björk I; Zettlmeissl G
    Arch Biochem Biophys; 1997 May; 341(2):212-21. PubMed ID: 9169007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin Phe229Leu: a new homozygous variant leading to spontaneous antithrombin polymerization in vivo associated with severe childhood thrombosis.
    Picard V; Dautzenberg MD; Villoutreix BO; Orliaguet G; Alhenc-Gelas M; Aiach M
    Blood; 2003 Aug; 102(3):919-25. PubMed ID: 12595305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.
    Zhu T; Ding Q; Bai X; Wang X; Kaguelidou F; Alberti C; Wei X; Hua B; Yang R; Wang X; Wang Z; Ruan C; Schlegel N; Zhao Y
    Haematologica; 2011 Jul; 96(7):1033-40. PubMed ID: 21486865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of AlphaFold and molecular dynamics structure predictions of mutations in serpins.
    Garrido-Rodríguez P; Carmena-Bargueño M; de la Morena-Barrio ME; Bravo-Pérez C; de la Morena-Barrio B; Cifuentes-Riquelme R; Lozano ML; Pérez-Sánchez H; Corral J
    PLoS One; 2024; 19(7):e0304451. PubMed ID: 38968282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome-wide analysis of single-nucleotide variations in the N-glycosylation sequon of human genes.
    Mazumder R; Morampudi KS; Motwani M; Vasudevan S; Goldman R
    PLoS One; 2012; 7(5):e36212. PubMed ID: 22586465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.